A detailed history of Oakmont Corp transactions in Amgen Inc stock. As of the latest transaction made, Oakmont Corp holds 198 shares of AMGN stock, worth $55,020. This represents 0.01% of its overall portfolio holdings.

Number of Shares
198
Previous 198 -0.0%
Holding current value
$55,020
Previous $61,000 3.28%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$255.7 - $288.46 $4,858 - $5,480
-19 Reduced 8.76%
198 $57,000
Q2 2023

Aug 07, 2023

SELL
$214.27 - $253.37 $11,570 - $13,681
-54 Reduced 19.93%
217 $48,000
Q2 2022

Aug 02, 2022

SELL
$230.71 - $256.74 $15,918 - $17,715
-69 Reduced 20.29%
271 $66,000
Q1 2022

May 16, 2022

BUY
$219.27 - $242.57 $74,551 - $82,473
340 New
340 $82,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $149B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Oakmont Corp Portfolio

Follow Oakmont Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oakmont Corp, based on Form 13F filings with the SEC.

News

Stay updated on Oakmont Corp with notifications on news.